Definitive Contract 75N91020C00040
Award Date 9/14/20
Potential Completion Date 9/13/21
Potential Value $6.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60606, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $224,759 Firm Fixed Price contract to Litmus Health, Inc., a small business, to develop an extensible and scalable platform for data integration from wearable sensors to generate novel analytics for cancer patients. This award is associated with the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS...
- This definitive contract was awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to Intelligent Automation, LLC. The $399,980 firm fixed price contract is for Phase I of the SBIR program's TOPIC 412, which seeks the development of a wearables-agnostic platform for continuous health monitoring and predictions to support cancer patients. The one-year period of performance will take place in Derwood,...
- This is a $358,456.00 firm fixed price purchase order awarded by the National Cancer Institute (NCI) to Actigraph L.L.C., doing business as Actigraph LLC, a for-profit organization that specializes in providing advanced wearable technology and data management solutions to facilitate clinical research. The contract supports the recovery and validation of biomarker-based diet and physical activity assessment tools for existing research cohorts. No set-aside designation was used for this award....
- The federal contract award is a Phase I Small Business Innovation Research contract valued at approximately $400,000 awarded by the National Institutes of Health National Cancer Institute to Charles River Analytics, Inc. of Cambridge, Massachusetts. The contract is for one year ending in June 2021 to conduct research and development in support of the agency's TOPIC 412: WEARABLE HEALTH INFORMATICS PLATFORM FOR EXTENSIBLE RESEARCH program. Specifically, the contractor will develop a wearable...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the National Institutes of Health at the U.S. Department of Health and Human Services. The contract, valued at $22,288, is for the provision of COVID-19 multimodal biosensors. The awardee is Ampx Technologies, Inc., a for-profit corporation that specializes in biosensor technology and electric vehicle research and development. This contract does not...
- This $2,049,554 firm fixed price definitive contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sentimetrix, Inc., a for-profit small business. The contract supports the SBIR Phase II effort for "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)," which was previously funded under a $454,907 SBIR Phase I contract in 2021. The PATHML effort aims to develop machine learning techniques to analyze human posture...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
- This is a $6,005.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse, part of the U.S. Department of Health and Human Services, to ActiGraph LLC, a for-profit company that provides specialized wearable devices, data hubs, and software for biomedical research. The contract has no set-aside designation. Based on the company's previous federal contracts with other NIH institutes, ActiGraph appears to specialize in providing advanced wearable technology and data...
- This $454,907 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Sentimetrix, Inc. for research under the SBIR Phase I topic "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)". The contract is associated with the Department of Health and Human Services' National Institutes of Health and Centers for Disease Control and Prevention SBIR solicitation seeking innovative solutions across cancer research, infectious diseases, public...
- Microhealth, LLC was awarded a $7,974,619.85 delivery order against the Chief Information Officer - Solutions and Partners 3, Small Business Government-wide Acquisition Contract by the Department of Health and Human Services National Institutes of Health National Technology Information Acquisition and Assessment Office. The delivery order is for NPIRS COVID 19 ENTERPRISE BI AND ANALYTICS ENHANCEMENT to provide enhanced business intelligence and analytics capabilities for NIH's National Program...
The National Institutes of Health's National Cancer Institute awarded a definitive $6.1 million firm fixed price contract to Physiq, Inc. of Chicago, Illinois. The contract is for the delivery of a personalized analytics wearable biosensor platform to enable early detection of COVID-19 decompensation. No major subcontractors or set aside designations were indicated. The one-year contract supports the Department of Health and Human Services' efforts to develop digital health solutions for monitoring and responding to the COVID-19 pandemic through innovative monitoring technologies for early warning signs.
Generated 12/29/23, 5:01 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 8/8/22 | |
| P00002 | Supplemental Agreement for work within scope | ($516k) | 10/18/21 | |
| P00001 | Exercise an Option | $4.3m | 12/30/20 | |
| Not listed | Not listed | $2.3m | 9/11/20 |